Cancers,
Год журнала:
2021,
Номер
13(22), С. 5741 - 5741
Опубликована: Ноя. 16, 2021
Cannabinoid
receptors,
which
are
widely
distributed
in
the
body,
have
been
considered
as
possible
pharmacological
targets
for
management
of
several
tumors.
type
2
receptors
(CB2Rs)
belong
to
G
protein-coupled
receptor
family
and
mainly
expressed
hematopoietic
immune
cells,
such
B-cells,
T-cells,
macrophages;
thus,
CB2R
activation
might
be
useful
treating
cancers
affecting
plasma
multiple
myeloma
(MM).
Previous
studies
shown
that
stimulation
may
anti-proliferative
effects;
therefore,
purpose
present
study
was
explore
antitumor
effect
beta-caryophyllene
(BCP),
a
agonist,
an
vitro
model
MM.
Dexamethasone-resistant
(MM.1R)
sensitive
(MM.1S)
human
cell
lines
were
used
this
study.
Cells
treated
with
different
concentrations
BCP
24
h,
group
cells
pre-incubated
AM630,
specific
antagonist.
treatment
reduced
proliferation
through
stimulation;
notably,
considerably
increased
pro-apoptotic
protein
Bax
decreased
anti-apoptotic
molecule
Bcl-2.
Furthermore,
increase
caspase
3
levels
detected
following
incubation,
thus
demonstrating
its
apoptosis
activation.
In
addition,
regulated
AKT,
Wnt1,
beta-catenin
expression,
showing
decrease
cancer
by
modulating
Wnt/β-catenin
signaling.
These
effects
counteracted
AM630
co-incubation,
confirming
BCP's
mechanism
action
is
related
modulation.
A
β-catenin
impaired
cycle
especially
promoted
cyclin
D1
CDK
4/6
reduction.
Taken
together,
these
data
revealed
significant
effective
anti-cancer
MM
activating
apoptosis,
molecular
pathways,
downregulating
cycle.
Cells,
Год журнала:
2021,
Номер
10(12), С. 3327 - 3327
Опубликована: Ноя. 26, 2021
The
cell
cycle
is
the
series
of
events
that
take
place
in
a
cell,
which
drives
it
to
divide
and
produce
two
new
daughter
cells.
typical
eukaryotes
composed
following
phases:
G1,
S,
G2,
M
phase.
Cell
progression
mediated
by
cyclin-dependent
kinases
(Cdks)
their
regulatory
cyclin
subunits.
However,
driving
force
growth
factor-initiated
signaling
pathways
control
activity
various
Cdk-cyclin
complexes.
While
mechanism
underlying
role
factor
G1
phase
has
been
largely
revealed
due
early
extensive
research,
little
known
regarding
function
regulating
other
phases
cycle,
including
In
this
review,
we
briefly
discuss
process
through
phases,
focus
on
activated
factors
receptor
(mostly
tyrosine
kinases)
phases.
Signal Transduction and Targeted Therapy,
Год журнала:
2023,
Номер
8(1)
Опубликована: Фев. 27, 2023
Targeted
anticancer
drugs
block
cancer
cell
growth
by
interfering
with
specific
signaling
pathways
vital
to
carcinogenesis
and
tumor
rather
than
harming
all
rapidly
dividing
cells
as
in
cytotoxic
chemotherapy.
The
Response
Evaluation
Criteria
Solid
Tumor
(RECIST)
system
has
been
used
assess
response
therapy
via
changes
the
size
of
target
lesions
measured
calipers,
conventional
anatomically
based
imaging
modalities
such
computed
tomography
(CT),
magnetic
resonance
(MRI),
other
methods.
However,
RECIST
is
sometimes
inaccurate
assessing
efficacy
targeted
because
poor
correlation
between
treatment-induced
necrosis
or
shrinkage.
This
approach
might
also
result
delayed
identification
when
does
confer
a
reduction
size.
Innovative
molecular
techniques
have
gained
importance
dawning
era
they
can
visualize,
characterize,
quantify
biological
processes
at
cellular,
subcellular,
even
level
anatomical
level.
review
summarizes
different
pathways,
various
techniques,
developed
probes.
Moreover,
application
for
evaluating
treatment
related
clinical
outcome
systematically
outlined.
In
future,
more
attention
should
be
paid
promoting
translation
sensitivity
biocompatible
particular,
multimodal
technologies
incorporating
advanced
artificial
intelligence
comprehensively
accurately
cancer-targeted
therapy,
addition
RECIST-based
Journal of Cancer,
Год журнала:
2021,
Номер
12(18), С. 5543 - 5561
Опубликована: Янв. 1, 2021
Reactive
oxygen
species
(ROS)
play
a
dual
role
in
the
initiation,
development,
suppression,
and
treatment
of
cancer.Excess
ROS
can
induce
nuclear
DNA,
leading
to
cancer
initiation.Not
only
that,
but
also
inhibit
T
cells
natural
killer
promote
recruitment
M2
polarization
macrophages;
consequently,
escape
immune
surveillance
defense.Furthermore,
tumor
invasion
metastasis
by
triggering
epithelial-mesenchymal
transition
cells.Interestingly,
massive
accumulation
inhibits
growth
two
ways:
(1)
blocking
cell
proliferation
suppressing
signaling
pathway,
cycle,
biosynthesis
nucleotides
ATP
(2)
inducing
death
via
activating
endoplasmic
reticulum
stress-,
mitochondrial-,
P53-apoptotic
pathways
ferroptosis
pathway.Unfortunately,
adapt
self-adaption
system.This
review
highlighted
bidirectional
regulation
cancer.The
study
further
discussed
application
massively
accumulated
treatment.Of
note,
self-adaptive
ability
should
be
taken
into
consideration
for
prevention.
Multidrug
resistance
(MDR)
mediated
by
ATP
binding
cassette
subfamily
B
member
1
(ABCB1/P-gp)
is
a
major
cause
of
cancer
chemotherapy
failure,
but
the
regulation
mechanisms
are
largely
unknown.Based
on
single
gene
knockout,
we
studied
CDK6-PI3K
axis
ABCB1-mediated
MDR
in
human
cells.
CRISPR/Cas9
technique
was
performed
KB-C2
cells
to
knockout
cdk6
or
cdk4
gene.
Western
blot,
RT-PCR
and
transcriptome
analysis
were
investigate
target
deletion
expression
critical
signaling
factors.
The
effect
deficiency
cell
apoptosis
cycle
analyzed
using
flow
cytometry.
In
vivo
studies
study
sensitivity
tumors
doxorubicin,
tumor
growth
metastasis.Deficiency
led
remarkable
downregulation
ABCB1
reversal
MDR.
Transcriptomic
revealed
that
CDK6
regulated
series
factors,
among
them,
PI3K
110α
110β,
KRAS
MAPK10
downregulated,
FOS-promoting
autophagy
CXCL1-regulating
multiple
factors
upregulated.
Notably,
110α/110β
in-return
downregulated
synergizes
regulating
expression,
which
strengthened
over
either
110α/110β.
High
frequency
alternative
splicing
(AS)
premature
mRNA
induced
CDK6,
CDK4
level
change
confirmed
alter
level,
them
10
common
skipped
exon
(SE)
events
found.
experiments
demonstrated
loss
remarkably
increased
doxorubicin
increasing
drug
accumulation
tumors,
resulting
inhibition
metastasis,
as
well
survival
nude
mice.CDK6-PI3K
new
reverse
reported
for
first
time
cancers.
Pathways
leading
proliferation
be
accompanied
deficiency.
Membranes,
Год журнала:
2023,
Номер
13(2), С. 167 - 167
Опубликована: Янв. 29, 2023
Mechanical
forces
are
an
inherent
element
in
the
world
around
us.
The
effects
of
their
action
can
be
observed
both
on
macro
and
molecular
levels.
They
also
play
a
prominent
role
tissues
cells
animals
due
to
presence
mechanosensitive
ion
channels
(MIChs)
such
as
Piezo
TRP
families.
essential
many
physiological
processes
human
body.
However,
pathology
has
been
observed.
Recent
discoveries
have
highlighted
relationship
between
these
development
malignant
tumors.
Multiple
studies
shown
that
MIChs
mediate
proliferation,
migration,
invasion
various
cancer
via
mechanisms.
This
could
show
new
potential
biomarkers
detection
prognosis
interesting
therapeutic
targets
modern
oncology.
Our
paper
is
review
latest
literature
Piezo1
families
mechanisms
carcinogenesis
different
types
cancer.
Cells,
Год журнала:
2021,
Номер
10(6), С. 1334 - 1334
Опубликована: Май 28, 2021
Historically,
metastatic
melanoma
was
considered
a
highly
lethal
disease.
However,
recent
advances
in
drug
development
have
allowed
significative
improvement
prognosis.
In
particular,
BRAF/MEK
inhibitors
and
anti-PD1
antibodies
completely
revolutionized
the
management
of
this
Nonetheless,
not
all
patients
derive
benefit
or
durable
from
these
therapies.
To
overtake
challenges,
new
clinically
active
compounds
are
being
tested
context
clinical
trials.
CDK4/6
drugs
already
available
practice
preliminary
evidence
showed
promising
activity
also
melanoma.
Herein
we
review
literature
to
depict
comprehensive
landscape
about
We
present
molecular
genetic
background
that
might
justify
usage
drugs,
preclinical
evidence,
data,
most
ongoing
Cancers,
Год журнала:
2025,
Номер
17(5), С. 832 - 832
Опубликована: Фев. 27, 2025
Melanoma
is
a
highly
heterogeneous
disease,
and
deeper
molecular
classification
essential
for
improving
patient
stratification
treatment
approaches.
Here,
we
describe
the
histopathology-driven
proteogenomic
landscape
of
142
treatment-naïve
metastatic
melanoma
samples
to
uncover
subtypes
clinically
relevant
biomarkers.
We
performed
an
integrative
analysis
identify
proteomic
subtypes,
assess
impact
BRAF
V600
mutations,
study
profiles
cellular
composition
tumor
microenvironment.
Clinical
histopathological
data
were
used
support
findings
related
tissue
morphology,
disease
progression,
outcomes.
Our
revealed
five
distinct
that
integrate
immune
stromal
microenvironment
components
correlate
with
clinical
parameters.
demonstrated
V600-mutated
melanomas
exhibit
biological
heterogeneity,
where
oncogene-induced
senescence-like
phenotype
associated
improved
survival.
This
led
proposed
mortality
risk-based
may
contribute
more
personalized
strategies.
Furthermore,
strongly
correlated
progression
outcomes,
highlighting
connective
tissue-to-tumor
ratio
assessment
as
potential
decision-making
tool.
identified
melanoma-associated
SAAV
signature
linked
extracellular
matrix
remodeling
SAAV-derived
neoantigens
targets
anti-tumor
responses.
provides
comprehensive
melanoma,
integrating
insights
features.
The
aid
in
development
tailored
diagnostic
therapeutic
strategies,
management